Replicating the success of the Centre of Excellence in the UK, the facility in Philadelphia offers design, laboratory and testing capabilities to develop temperature-controlled solutions.
The 26,000 square foot building strengthens Tower’s container conditioning and storage capabilities, and will serve pharmaceutical, airlines and 3PL customers across the Americas.
The headquarters also has office space for customers, offering opportunities for meetings, demonstrations and product development in partnership with customers.
Establishing a Centre of Excellence in the Americas will strengthen Tower Cold Chain’s collaborative partnerships with manufacturers, airlines and 3PL providers in the region, serving as a hub of innovation and expertise.
Niall Balfour, CEO of Tower Cold Chain, says, “This marks a significant step in Tower’s growth trajectory. As demand for robust, reliable, reusable pharmaceutical logistics continues to surge, our investment in strategic locations enables us to provide essential support for the seamless transportation of temperature-sensitive pharmaceutical and life-science products.”
Tower Cold Chain will hold an official Open Day on 12 September when customers, partners and industry stakeholders will be invited to the facility.